SK
Santosh Kaul
About Santosh Kaul
Data last updated:
Santosh Kaul is a Director at Numarck Medicals Private Limited (since 2017) and Director at Unimarck Bioethicals Private Limited (since 2005). The companies operate in Healthcare and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹1.30 Cr; the largest is Numarck Medicals Private Limited at ₹69.7 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Feb 2017 | 2017 | ₹69.7 Lakh (FY 2024) | Active | |
| Director | 30 Dec 2005 | 2005 | ₹60.5 Lakh (FY 2024) | Active |
Board colleagues of Santosh Kaul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Viveak Kaul | 02368844 | Numarck Medicals Private Limited | Director |
| Virender Kumar Kaul | 02089567 | Unimarck Bioethicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Kaul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Kaul
Santosh Kaul currently holds 2 directorships: Numarck Medicals Private Limited (Director, since 27 Feb 2017, revenue ₹69.7 Lakh (FY 2024)); Unimarck Bioethicals Private Limited (Director, since 30 Dec 2005, revenue ₹60.5 Lakh (FY 2024)).
Santosh Kaul was first appointed on 30 Dec 2005 as Director at Unimarck Bioethicals Private Limited. The most recent appointment on record is 27 Feb 2017 at Numarck Medicals Private Limited.
The 2 current companies of Santosh Kaul that report revenue have a combined latest revenue of ₹1.30 Cr: Numarck Medicals Private Limited ₹69.7 Lakh (FY 2024); Unimarck Bioethicals Private Limited ₹60.5 Lakh (FY 2024).
The current boards of Santosh Kaul's companies include Viveak Kaul (Numarck Medicals Private Limited), Virender Kumar Kaul (Unimarck Bioethicals Private Limited).